Bédard, Karine
Boisvert, Isabelle
Rochette, Marianne
Racine, Eric
Martel-Laferrière, Valérie
Funding for this research was provided by:
Canadian Research Initiative in Substance Misuse
Clinician Research Scholars– Junior 2 program of the Fonds de Recherche du Québec en Santé
Article History
Received: 8 February 2024
Accepted: 7 February 2025
First Online: 14 February 2025
Declarations
:
: This research project was approved by the CHUM Research Ethics Committee (21.372). Participants were required to sign an informed consent form prior to engaging in a focus group. The study was conducted in accordance with the principles of the Declaration of Helsinki.
: Not applicable.
: VML: research grants from Gilead and Merck, conference for AbbVie. The other authors declare that they have no competing interests.